Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.48%
#4 aPriori aPriori +113.53%
#5 Bedrock Bedrock +74.54%
#6 Cysic Cysic +46.36%
#7 Prom Prom +40.86%
#8 Playnance Playnance +35.16%
#9 COTI COTI +30.93%
#10 Nillion Nillion +22.86%
Coin of the day
Wrapped One Wrapped One
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Rankning i aktier #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Aktiekurs
$0.00023723
Senast synkroniserad: 2024-08-26
Marknadsvärde
$1.41K
Förändring (1 dag)
111.67%
Förändring (1 år)
0.00%
Land
FR
Handel Pharnext S.A. (ALPHA)

Kategori

Healthcare
Vinst för Pharnext S.A. (ALPHA)
Vinst i Dec 2023 TTM: $-31.69M
Enligt de senaste finansiella rapporterna från Pharnext S.A. är företagets nuvarande vinst $-31.69M. År 2022 hade företaget en vinst på $-43.29M, en minskning jämfört med vinsten år 2021 som var $-38.48M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Pharnext S.A. från 2013 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
2026 (TTM) $-31.69M 1.28%
2023 $-31.29M -27.73%
2022 $-43.29M 12.50%
2021 $-38.48M 30.75%
2020 $-29.43M -0.92%
2019 $-29.70M 21.26%
2018 $-24.50M -15.52%
2017 $-29.00M 29.32%
2016 $-22.42M 87.83%
2015 $-11.94M -8.06%
2014 $-12.98M 1.29%
2013 $-12.82M 0.00%
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -16,747.05%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -6,256.06%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -9,585.74%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR